Finding new ways to grow

Discover the power of a broad transformation so your business thrives in today's dynamic environment — and tomorrow’s.

Talk to our professionals

Learn how we can help you make the most of your business transformation.

Driving tomorrow’s growth with yesterday’s strategies isn’t an option. The business landscape won’t allow it. The environment is too dynamic. Too volatile. That why companies need a holistic approach to transformation that fuels growth while balancing risk and opportunity.

Successful business transformation for life sciences companies extends beyond financial improvement. Portfolio transformation, supply chain optimization and enhanced operational efficiency are critical. What’s key is driving transformation from the intersection of strategy and technology. This means integrating strategic and tech-powered operations, ensuring that every process is aligned with broader business goals while optimizing performance. It’s a powerful shift.

Advanced technologies such as AI-driven analytics, IT/OT convergence, smart manufacturing systems and integrated ERP solutions can facilitate this powerful shift. These tools are essential to realize the potential of smart factories, streamline operations and support seamless transitions between operational phases. This shift is not merely about upgrading systems. It’s about fundamentally and broadly rethinking business practices to foster efficiency, resilience and growth. 


Portfolio transformation 

Strategic portfolio transformation helps life sciences companies grow and stay competitive by focusing on key acquisitions, partnerships, and divesting non-core assets. Companies should align their portfolio with business goals, identifying valuable acquisitions and leveraging tech partnerships for faster growth. Continual reassessment is crucial to adapt to market changes and stay competitive.


Plan for resilience 

 

Improving supply chain resilience is key in life sciences. Getting there demands better visibility across the supplier base.

Hand of woman assembling pieces of wooden puzzle

Navigate M&A risk 

 

Focused on M&A? Be certain to consider global trade and VAT implications during due diligence. 

Modern medical research laboratory

Supply chain optimization  

The supply chain is vital, yet many life sciences companies lack full visibility. To transform, companies should improve transparency, optimize sourcing and consolidate platforms for an AI-driven, resilient supply chain. Exploring regional sourcing, supplier diversification, and cloud ecosystems can drive innovation and create more efficient, sustainable supply chains.


Make the right deals

 

Life sciences companies are pivoting to dealmaking again. How can they target deals to deliver value now and in the future?

Close-up of brown glass medicine bottles at production line

Get future ready

 

The global pandemic changed everything for the pharmaceutical supply chain. Explore research insights into its future.  

Medical research scientist conducting experiments under microscope

Our latest thinking

How biopharmas can create long-term growth focusing on sustainability

In health care, there is a growing need to embed the perspectives of diverse stakeholders in the sustainability agenda.

The Unstoppables: Success stories of the world’s most inspiring entrepreneurs

The latest EY entrepreneurship documentary, “The Unstoppables 3,” features inspiring professional and personal entrepreneur success stories. Read more.

How life sciences can make the right deals in a time of change

Life sciences companies are returning to dealmaking amid cost and revenue pressures – how will they find the right deals to secure value? Learn more.

How will you respond to clinicians sounding the alarm on unsustainable care delivery models?

The EY Global Voices in Health Care Study finds health systems must embrace sustainable care delivery models to address workforce challenges. Learn more.

How do you build future supply chains to best serve patient needs?

In the wake of global disruptions, EY research aims to map out the future for supply chain transformation in the pharmaceutical industry. Read more.

How digital is changing the tax strategy for MedTech

As MedTech companies make substantial investments in digital technology, there are important tax implications that should be addressed. Learn more.

How Takeda accelerated the financial close process by nearly two weeks

In this case study, learn how leading pharmaceutical company Takeda is creating value for patients through finance innovation and process excellence.

How early diagnosis can transform health care

Mirxes’ Dr. Zhou Lihan shares his purpose and passion for a more proactive approach to medicine. Learn more.

How innovation can unlock the power of data to deliver value-based care

Organizations have the tools to deliver a better personalized health experience, but the ecosystem needs to collaborate to build this future. Learn more.